|
[1]
|
Stem cell-based therapy for fibrotic diseases: mechanisms and pathways
Stem Cell Research & Therapy,
2024
DOI:10.1186/s13287-024-03782-5
|
|
|
|
|
[2]
|
Cellular therapies for idiopathic pulmonary fibrosis: current progress and future prospects
American Journal of Stem Cells,
2024
DOI:10.62347/DAKS5508
|
|
|
|
|
[3]
|
Effects of transplanted mesenchymal stem cells on repair of the lung tissue of rats with experimental pulmonary fibrosis
Regulatory Mechanisms in Biosystems,
2022
DOI:10.15421/022240
|
|
|
|
|
[4]
|
Adipose-derived stromal vascular fraction: mechanism of action, prospects and risks of local application
Plasticheskaya khirurgiya i esteticheskaya meditsina,
2019
DOI:10.17116/plast.hirurgia201902143
|
|
|
|
|
[5]
|
Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia
Scientific Reports,
2017
DOI:10.1038/s41598-017-15022-3
|
|
|
|
|
[6]
|
Cell-based therapies for the treatment of idiopathic pulmonary fibrosis (IPF) disease
Expert Opinion on Biological Therapy,
2016
DOI:10.1517/14712598.2016.1124085
|
|
|
|
|
[7]
|
Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis
Stem Cell Research & Therapy,
2015
DOI:10.1186/s13287-015-0081-6
|
|
|
|
|
[8]
|
Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis
Stem Cell Research & Therapy,
2015
DOI:10.1186/s13287-015-0081-6
|
|
|
|
|
[9]
|
The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice
Experimental Lung Research,
2014
DOI:10.3109/01902148.2014.881930
|
|
|
|
|
[10]
|
A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis
Journal of Translational Medicine,
2013
DOI:10.1186/1479-5876-11-171
|
|
|
|